This study reviewed 70 articles of published research to try to determine appropriate clinical guidelines for treating patients with chronic pain. It was published in the journal Cannabis & Cannabinoid Research in March 2023.
"Significant group differences in symptom relief were found across the chemovars".
Spoiler: Above average amounts of Myrcene and Terpinolene (between 0.5% and 1.0%) with THC levels between 15% and 25% were reported to be the most effective ("reliably stronger therapeutic effects").
Shopping Cart
Your cart is currently empty.
Enable cookies to use the shopping cart